UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023932
Receipt number R000027455
Scientific Title A study for investigating preventive effects of yogurt on the development of flulike symptoms
Date of disclosure of the study information 2016/09/10
Last modified on 2018/05/23 10:20:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for investigating preventive effects of yogurt on the development of flulike symptoms

Acronym

A study for investigating preventive effects of yogurt on the development of flulike symptoms

Scientific Title

A study for investigating preventive effects of yogurt on the development of flulike symptoms

Scientific Title:Acronym

A study for investigating preventive effects of yogurt on the development of flulike symptoms

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to evaluate the influence of successive intake of yogurt on (1) prevention of the development of flulike symptoms, (2) immune responses and (3) health related quality of life.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cumulative incidence of influenza

Key secondary outcomes

Symptoms of the common cold (incidence, frequency and severity)
Immunological tests using bloods
Health related quality of life


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Consumption of yogurt for 16 weeks

Interventions/Control_2

non-consumption of yogurt for 16 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1) Female subjects aged twenty or more
Licentiates working in medical institutes as health or welfare professional
(2) Subjects who can understand the purpose and the contents of this study, and can agree to participation in this study by letter

Key exclusion criteria

(1) Pregnant women
(2) Subjects who contracted influenza during the period of July 2016 to the date of giving written informed consent
(3) Subjects who show allergic responses to dairy products
(4) Lactose intolerant subjects
(5) Subjects who are instructed to restrict calories by physician
(6) Subjects with a history of diseases involving the immune system (e.g. rheumatism, cancer, thyroid disorder, systemic erythematodes, myasthenia gravis, graves disease, scleroderma )
(7) Subjects who have participated in other clinical tests within the past three months
(8) Subjects who were judged inadequate by investigator for other reasons

Target sample size

1200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Isao Saito

Organization

Ehime University Graduate School of Medicine

Division name

Department of Basic Nursing and Health Science

Zip code


Address

454 Shizukawa, Toon, Ehime

TEL

089-964-5111

Email

saitoi@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsu Kinoshita

Organization

Institute of Community Life Sciences Co., Ltd.

Division name

Social Epidemiology Institute

Zip code


Address

1383-2 hiraimachi, Matsuyama, Ehime

TEL

089-904-7811

Homepage URL


Email

tetsu@shin-science.co.jp


Sponsor or person

Institute

Ehime University

Institute

Department

Personal name



Funding Source

Organization

Meiji Co.,ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 22 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 13 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 05 Day

Last modified on

2018 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027455


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name